KDNY - Chinook Therapeutics GAAP EPS of -$2.26 revenue of $51.62M March, 17 2022 05:38 PM Chinook Therapeutics Inc Com Chinook Therapeutics press release (NASDAQ:KDNY): FY GAAP EPS of -$2.26. Revenue of $51.62M (+6195.1% Y/Y). For further details see: Chinook Therapeutics GAAP EPS of -$2.26, revenue of $51.62M